Viewing Study NCT05038657


Ignite Creation Date: 2025-12-24 @ 6:57 PM
Ignite Modification Date: 2025-12-28 @ 3:24 PM
Study NCT ID: NCT05038657
Status: UNKNOWN
Last Update Posted: 2022-10-03
First Post: 2021-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).
Sponsor: University Hospital Southampton NHS Foundation Trust
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module